OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 5847 citing articles:

A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang, Pierre Hainaut, Gregory J. Gores, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 10, pp. 589-604
Open Access | Times Cited: 3461

Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
Marc Arbyn, Elisabete Weiderpass, Laia Bruni, et al.
The Lancet Global Health (2019) Vol. 8, Iss. 2, pp. e191-e203
Open Access | Times Cited: 3352

Burden of liver diseases in the world
Sumeet K. Asrani, Harshad Devarbhavi, John E. Eaton, et al.
Journal of Hepatology (2018) Vol. 70, Iss. 1, pp. 151-171
Closed Access | Times Cited: 3093

The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
Tomi Akinyemiju, Semaw Ferede Abera, Muktar Beshir Ahmed, et al.
JAMA Oncology (2017) Vol. 3, Iss. 12, pp. 1683-1683
Open Access | Times Cited: 1748

Head and Neck Cancer
Laura Q.M. Chow
New England Journal of Medicine (2020) Vol. 382, Iss. 1, pp. 60-72
Closed Access | Times Cited: 1521

Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Daniel Q. Huang, Hashem B. El–Serag, Rohit Loomba
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 4, pp. 223-238
Open Access | Times Cited: 1371

Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
Jonathan Kocarnik, Kelly Compton, Frances Dean, et al.
JAMA Oncology (2021) Vol. 8, Iss. 3, pp. 420-420
Open Access | Times Cited: 1360

Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Karol Bukowski, Mateusz Kciuk, Renata Kontek
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3233-3233
Open Access | Times Cited: 1305

Chemotherapy for advanced gastric cancer
Dorothea Wagner, Nicholas Syn, Markus Moehler, et al.
Cochrane library (2017) Vol. 2017, Iss. 8
Open Access | Times Cited: 1250

The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni, Helen K. Angell, Jérôme Galon
Nature reviews. Cancer (2020) Vol. 20, Iss. 11, pp. 662-680
Closed Access | Times Cited: 1221

ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer
Andrew J. Armstrong, Russell Z. Szmulewitz, Daniel P. Petrylak, et al.
Journal of Clinical Oncology (2019) Vol. 37, Iss. 32, pp. 2974-2986
Open Access | Times Cited: 919

DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
Ruixue Huang, Ping‐Kun Zhou
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 823

Key steps for effective breast cancer prevention
Kara L. Britt, Jack Cuzick, Kelly‐Anne Phillips
Nature reviews. Cancer (2020) Vol. 20, Iss. 8, pp. 417-436
Closed Access | Times Cited: 805

Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
Luca Falzone, Salvatore Salomone, Massimo Libra
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 792

The Epidemiology of Prostate Cancer
Claire H. Pernar, Ericka M. Ebot, Kathryn M. Wilson, et al.
Cold Spring Harbor Perspectives in Medicine (2018) Vol. 8, Iss. 12, pp. a030361-a030361
Open Access | Times Cited: 658

Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies
Yunhe Wang, Jinqiao Li, Jufang Shi, et al.
Molecular Psychiatry (2019) Vol. 25, Iss. 7, pp. 1487-1499
Closed Access | Times Cited: 649

The global burden of disease attributable to high body mass index in 195 countries and territories, 1990–2017: An analysis of the Global Burden of Disease Study
Haijiang Dai, Tariq A. Alsalhe, Nasr Chalghaf, et al.
PLoS Medicine (2020) Vol. 17, Iss. 7, pp. e1003198-e1003198
Open Access | Times Cited: 649

Measuring population ageing: an analysis of the Global Burden of Disease Study 2017
Angela Y. Chang, Vegard Skirbekk, Stefanos Tyrovolas, et al.
The Lancet Public Health (2019) Vol. 4, Iss. 3, pp. e159-e167
Open Access | Times Cited: 621

Epidemiology of esophageal cancer: update in global trends, etiology and risk factors
Dustin Uhlenhopp, Eric O. Then, Tagore Sunkara, et al.
Clinical Journal of Gastroenterology (2020) Vol. 13, Iss. 6, pp. 1010-1021
Closed Access | Times Cited: 601

Epidemiology of lung cancer
Krishna Chaitanya Thandra, Adam Barsouk, Kalyan Saginala, et al.
Współczesna Onkologia (2021) Vol. 25, Iss. 1, pp. 45-52
Open Access | Times Cited: 600

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
Ezra E.W. Cohen, R. Bryan Bell, Carlo Bifulco, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 597

The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention
Zhenqiu Liu, Yanfeng Jiang, Huangbo Yuan, et al.
Journal of Hepatology (2018) Vol. 70, Iss. 4, pp. 674-683
Closed Access | Times Cited: 592

Dengue
Annelies Wilder‐Smith, Eng Eong Ooi, Olaf Horstick, et al.
The Lancet (2019) Vol. 393, Iss. 10169, pp. 350-363
Closed Access | Times Cited: 554

Page 1 - Next Page

Scroll to top